Leadership
Eurofins Transplant Genomics is spearheaded by a passionate, hardworking, Executive Leadership Team. Click below to learn more.
Vishal Sikri
Vishal Sikri has over 24 years of Oncology and Infectious Disease diagnostics experience in both the global IVD and LDT settings. His last 15 years has been focused primarily in Oncology especially in solid tumor tissue and liquid biopsies across multiple testing modalities. He previously was the commercial officer at Sysmex Inostics, a liquid biopsy ctDNA company. From there, he moved to Biocartis US, where he was the General Manager, responsible for all commercial and operational activities, selling instruments and solid tumor Oncology tests to hospitals and testing labs in the US. He then moved to Invitae where the team launched the company’s first MRD (Minimal Residual Disease) tests clinically. Vishal recently served as the President of Advanced Diagnostics at NeoGenomics, a large community focused reference lab company. Vishal joined the ETG team in January of 2025.
President, Eurofins Transplant Genomics, LLC
Neal Beswick
Neal joined Transplant Genomics in August 2020 and is the VP of commercial operations. Neal has worked in the commercial transplant field for over 15 years focused on advanced preservation systems for all solid organs and molecular biomarkers for the kidney and liver during his 4 year tenure at Transplant Genomics. The transplant field and more specifically the pursuit of improving patient outcomes post-transplant is a passion for Neal where knowledge and imagination can fuel much needed innovation in guiding monitoring and therapy titration.
Vice President of Commercialization
Jennifer Brockmeier
.
Senior Finance Manager
Steve Kleiboeker, DVM, PhD
Steve Kleiboeker, DVM, PhD, Vice President of Research and Development, is responsible for the scientific direction and oversight of the Company’s research and development programs. Dr. Kleiboeker’s research focuses on diagnostic virology, immunology and infectious diseases as well as transplant monitoring. He is board certified as a high-complexity laboratory director, technical supervisor and clinical consultant by the American Board of Bioanalysis. Dr. Kleiboeker received his PhD and DVM from the University of Missouri.
Vice President of Research and Development & Lab Director